An adult female neutered domestic shorthair cat developed right heart failure 1 week after having surgical drainage of a neck abscess of unknown etiology established at our hospital. Echocardiography revealed a large vegetative mass adhered to the tricuspid valve. Post-mortem examination revealed fibrinous endocarditis and myocarditis associated with the presence of a grass awn (Hordeum species) foreign body. Foxtail migration with subsequent thrombus and endocarditis formation on the tricuspid valve is considered a very unusual sequel to foxtail migration.
Objective-To investigate the new onset of mitral regurgitation in patients with otherwise normal echocardiograms after anthracycline treatment and to assess its relation to other selected indicators of myocardial damage. Design-Prospective echocardiographic and electrocardiographic study. Setting-Tertiary paediatric cardiac referral centre. Patients-305 patients, aged 2-33 years (median 14 years), treated with cumulative anthracycline doses of between 150-450 mg/m 2 (median 180 mg/m 2 ) for childhood malignancy. Main outcome measures-Colour flow Doppler detection of mitral regurgitation and its relation to changes in echocardiographic indices of left ventricular function (systolic and diastolic dimensions, fractional shortening) and to changes in the 12 lead ECG; and the prevalence of mitral regurgitation in the anthracycline treated patients in comparison with previously studied normal volunteers of similar age. Results-34 patients (11.6%) developed ultrasound detectable mitral regurgitation, which was not apparent clinically, during or after anthracycline treatment, compared with only 1.8% of a normal population of similar age (p < 0.0001). Nine of the 34 also developed non-specific T wave abnormalities. All 34 patients had normal systolic function at the time of initial detection of mitral regurgitation, but four later developed impaired left ventricular function (5,11, 20, and 27 months after the first detection of mitral regurgitation). Conclusions-Mitral regurgitation occurs much more often in patients treated with anthracyclines than in the normal population. Echocardiographic detection of new mitral regurgitation with or without ECG abnormalities may be an early predictor of anthracycline cardiomyopathy. (Heart 2001;85:430-432)
Objective-To determine the prevalence and characteristics of left sided valvar regurgitation in normal children and adolescents. Design-Prospective observational study. Setting-Tertiary paediatric referral centre. Patients-329 volunteers (194 male, 135 female, age range 3-18 years). Main outcome measures-Detection of regurgitation with colour flow mapping after valve closure. Measurement of jet area, maximal velocity, and duration. Results-Mitral regurgitation was present in six subjects (1.82%, 95% confidence interval (CI) 0.38% to 3.3%) and was not seen before 7 years of age. The jets ranged from 1.1 to 1.9 cm 2 (mean 1.4 cm 2 ) in area and were confined to the proximal half of the left atrium. All of the detectable jets were pansystolic and five of six arose from the posteriomedial aspect of the mitral valve. Aortic regurgitation was seen in one girl aged 11 years (0.3%, 95% CI 0% to 0.9%). The signal was pandiastolic and 0.44 cm 2 in area. Conclusions-True mitral regurgitation occurring after rather than during mitral valve closure was detected in < 2% of subjects. These data support previous work in adult patients suggesting that trivial degrees of mitral regurgitation may be related to the process of aging. Aortic regurgitation is very rare in normal children and adolescents and should not be considered as a normal finding.
To the authors' knowledge, this is the first report with histologic evidence of pheochromocytoma and clinical presentation of third-degree AV block in dogs. In human literature, simultaneous presentation of both disease states is rare and has been infrequently reported.
OBJECTIVE To determine whether left atrial decompression (LAD) would reduce left atrial pressure (LAP) in dogs with advanced myxomatous mitral valve disease (MMVD) and left-sided congestive heart failure (CHF) and to describe the LAD procedure and hemodynamic alterations and complications. ANIMALS 17 dogs with advanced MMVD and left-sided CHF that underwent LAD. PROCEDURES The medical record database was retrospectively reviewed for all LAD procedures attempted in dogs with MMVD and left-sided CHF between October 2018 and June 2019. Data were collected regarding signalment (age, breed, weight, and sex), clinical signs, treatment, physical examination findings, and diagnostic testing before and after LAD. Procedural data were also collected including approach, technique, hemodynamic data, complications, and outcome. RESULTS 18 LAD procedures performed in 17 patients were identified. Dogs ranged in age from 7.5 to 16 years old (median, 11 years) and ranged in body weight from 2.9 to 11.6 kg (6.4 to 25.5 lb) with a median body weight of 7.0 kg (15.4 lb). Minimally invasive creation of an atrial septal defect for the purpose of LAD was successful in all dogs without any intraoperative deaths. Before LAD, mean LAP was elevated and ranged from 8 to 32 mm Hg with a median value of 14 mm Hg (reference value, < 10 mm Hg). Following LAD, there was a significant decrease in mean LAP (median decrease of 6 mm Hg [range, 1 to 15 mm Hg]). Survival time following LAD ranged from 0 to 478 days (median, 195 days). CONCLUSIONS AND CLINICAL RELEVANCE For dogs with advanced MMVD and left-sided CHF, LAD resulted in an immediate and substantial reduction in LAP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.